|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8-9
|
|
pubmed:dateCreated |
2008-9-12
|
|
pubmed:abstractText |
Anaplastic astrocytomas (AA) and glioblastomas (GB) are the most common malignant gliomas, and despite newly developed drugs and combined treatments, they still have an adverse prognosis. Paclitaxel is a cytotoxic agent with radiosensitizing properties and exerts objective growth inhibition in glioma tumor cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1423-0240
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
435-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18787350-Adult,
pubmed-meshheading:18787350-Antineoplastic Agents,
pubmed-meshheading:18787350-Brain Neoplasms,
pubmed-meshheading:18787350-Female,
pubmed-meshheading:18787350-Glioma,
pubmed-meshheading:18787350-Humans,
pubmed-meshheading:18787350-Male,
pubmed-meshheading:18787350-Middle Aged,
pubmed-meshheading:18787350-Neoadjuvant Therapy,
pubmed-meshheading:18787350-Paclitaxel,
pubmed-meshheading:18787350-Survival Analysis,
pubmed-meshheading:18787350-Survival Rate,
pubmed-meshheading:18787350-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment.
|
|
pubmed:affiliation |
Department of Surgery and Anatomy, Ribeirão Preto School of Medicine, University of São Paulo, RADIUM Institute of Radiotherapy, Campinas, Brazil.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
